PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

Clinical trial NCT06133517 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06133517
Sponsor: Fundación para el Progreso de la Oncología en Cantabria
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Bladder Carcinoma

Start date: 2025-01-20
Primary completion: 2030-01-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.